Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

December 13, 2022

Study Completion Date

December 13, 2022

Conditions
Healthy Subjects
Interventions
DRUG

Midazolam Syrup

Administered Midazolam Syrup 5 mg orally once daily in fed state;

DRUG

HEC74647PA

Administered HEC74647PA 100 mg orally once daily in fed state;

DRUG

HEC110114

Administered HEC110114 600 mg orally once daily in fed state;

Trial Locations (1)

130000

First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY